drug
ceftaroline fosamil
Marketedupdated 3mo agoby Apotex Corp
Approvedcommunity read0 votes
all catalysts(0)
nothing on the calendar yet
Trials studying ceftaroline fosamil
Patent cliff
source: FDA Orange Bookfirst barrier falls
Sep 21, 2030
~4.1 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (4)
- Feb 10, 2031formulationUS 82474004.5y
- Feb 10, 2031formulationUS 82474004.5y
- Sep 21, 2030formulationUS 96298614.1y
- Sep 21, 2030formulationUS 96298614.1y
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 43m ago
Found something off?
comments(0)
5-min edit window · permanent after that